Pros
Work life balance is good, minimal requirement to be in the office The mission is genuinely meaningful. Genomics and rare disease research is important work and that does lend a sense of purpose that you don't get in purely commercial environments The business attracts smart people and many colleagues are a delight to work with Good holiday allowance
Cons
If you're joining for the money, don't. Pay awards are a joke, routinely failing to keep pace with inflation let alone reflect actual contribution. Don't expect to be rewarded for impact. The ceiling is low and the appetite to recognise genuine performance is lower. What makes the pay situation even more galling is the process used to determine your meagre award. Line managers have so little visibility of their team's actual work that performance reviews appear to be little more than a Copilot-generated summary of peer feedback, dressed up with a rating and called a review. Vapid, hollow, and devoid of any genuine managerial insight. Your career trajectory is effectively determined by someone who couldn't pick your work out of a lineup without a chatbot summarizing it for them first. Progression? Technically it exists on paper. In practice, when your annual review is essentially conducted by an AI proxy, the idea that this process could meaningfully support your development is laughable. If delivering real change is what motivates you, look elsewhere. Any meaningful progress is suffocated under an ever-expanding blanket of unnecessary red tape and process theatre. The organization has wholeheartedly embraced the flat Spotify model, which in practice means an endless parade of people who feel thoroughly entitled to an opinion on things they neither own nor need to understand. Decisions that should take days take months, derailed by loud, performative objections from people whose primary contribution appears to be making themselves visible by blocking others. It's a culture of look-at-me-ism masquerading as collaboration. People exist not to deliver, but to be seen objecting. The path of least resistance is to do nothing, and the loudest voice in the room is rarely the most informed one. The talent will leave. The mediocrity will remain. And Copilot will give them all a glowing review.